Cambridge Investment Research Advisors Inc. increased its stake in DCP Midstream, LP (NYSE:DCP – Get Rating) by 17.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,225 shares of the pipeline company’s stock after acquiring an additional 1,351 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in DCP Midstream were worth $347,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of DCP. Invesco Ltd. lifted its stake in shares of DCP Midstream by 1,475.1% in the 1st quarter. Invesco Ltd. now owns 1,512,263 shares of the pipeline company’s stock valued at $50,752,000 after acquiring an additional 1,416,254 shares during the last quarter. Bank of America Corp DE raised its position in DCP Midstream by 181.5% during the 1st quarter. Bank of America Corp DE now owns 927,060 shares of the pipeline company’s stock valued at $31,112,000 after purchasing an additional 597,753 shares during the last quarter. Natixis raised its position in DCP Midstream by 209.3% during the 2nd quarter. Natixis now owns 675,200 shares of the pipeline company’s stock valued at $19,972,000 after purchasing an additional 456,900 shares during the last quarter. UBS Group AG raised its position in DCP Midstream by 23.5% during the 2nd quarter. UBS Group AG now owns 1,611,273 shares of the pipeline company’s stock valued at $47,661,000 after purchasing an additional 306,666 shares during the last quarter. Finally, ING Groep NV bought a new position in DCP Midstream during the 1st quarter valued at approximately $8,098,000. Institutional investors own 35.49% of the company’s stock.
DCP Midstream Stock Performance
DCP Midstream stock opened at $41.98 on Friday. The company has a quick ratio of 0.81, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The company has a market capitalization of $8.75 billion, a P/E ratio of 8.35 and a beta of 2.45. The stock’s 50 day moving average is $39.10 and its 200 day moving average is $36.86. DCP Midstream, LP has a twelve month low of $25.79 and a twelve month high of $42.15.
Analysts Set New Price Targets
A number of research analysts have commented on the company. Wells Fargo & Company lowered DCP Midstream from an “overweight” rating to an “equal weight” rating and lowered their price target for the company from $45.00 to $39.00 in a research report on Friday, November 11th. Raymond James downgraded DCP Midstream from a “strong-buy” rating to a “market perform” rating in a report on Monday. StockNews.com downgraded DCP Midstream from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 3rd. Mizuho downgraded DCP Midstream from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $45.00 to $42.00 in a report on Thursday. Finally, JPMorgan Chase & Co. downgraded DCP Midstream from an “overweight” rating to a “neutral” rating and set a $45.00 target price on the stock. in a report on Wednesday, November 2nd. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $40.71.
DCP Midstream Company Profile
DCP Midstream, LP, together with its subsidiaries, owns, operates, acquires, and develops a portfolio of midstream energy assets in the United States. The company operates through Logistics and Marketing, and Gathering and Processing. The Logistics and Marketing segment engages in transporting, trading, marketing, and storing natural gas and natural gas liquids (NGLs); and fractionating NGLs.
Further Reading
- Get a free copy of the StockNews.com research report on DCP Midstream (DCP)
- Deere, Catepillar, PACCAR, Machinery Stocks You Need to Know
- 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023
- Optimism About Global Demand For Metals Boosts BHP, Other Miners
- Exxon Mobil Expects Earnings and Cash Flow to Grow
- Sorrento Therapeutics, Scilex: 2 Hot Pharma Stocks On the Move
Receive News & Ratings for DCP Midstream Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DCP Midstream and related companies with MarketBeat.com's FREE daily email newsletter.